IgA Nephropathy: A Disease in Search of a Large-Scale Clinical Trial to Reliably Inform Practice Giovanni F.M. Strippoli, MD, PhD, MPH (Hons), MM (Epi), Ausilia Maione, MSc PharmChem, Francesco P. Schena, MD, G. Tognoni, MD, Jonathan C. Craig, MD, PhD, MM (Clin Epi) American Journal of Kidney Diseases Volume 53, Issue 1, Pages 5-8 (January 2009) DOI: 10.1053/j.ajkd.2008.10.035 Copyright © 2008 National Kidney Foundation, Inc. Terms and Conditions
Figure 1 Effect of corticosteroids versus comparator treatments on doubling of creatinine in patients with IgA nephropathy. American Journal of Kidney Diseases 2009 53, 5-8DOI: (10.1053/j.ajkd.2008.10.035) Copyright © 2008 National Kidney Foundation, Inc. Terms and Conditions
Figure 2 Effect of corticosteroids versus comparator treatments on proteinuria in patients with IgA nephropathy. American Journal of Kidney Diseases 2009 53, 5-8DOI: (10.1053/j.ajkd.2008.10.035) Copyright © 2008 National Kidney Foundation, Inc. Terms and Conditions